Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous dexmedetomidine and inflammatory mediators in total abdominal hysterectomy
IRCT20180506039558N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dexmedetomidine in hysterectomy (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Erythrocyte sedimentation rate, C-reactive protein and 4 more. Started Jul 2018; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
hysterectomy
Beyond the preview
Go deeper on IRCT20180506039558N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180506039558N1.